BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36093533)

  • 1. Hemophagocytic lymphohistiocytosis in two patients following treatment with pembrolizumab: two case reports and a literature review.
    Wei Y; He W; Sun W; Wu C; Ren D; Wang X; Zhang M; Huang M; Ji N
    Transl Cancer Res; 2022 Aug; 11(8):2960-2966. PubMed ID: 36093533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
    Noseda R; Bertoli R; Müller L; Ceschi A
    J Immunother Cancer; 2019 May; 7(1):117. PubMed ID: 31046841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
    Wang C; Sun W; Li Z; Wu T; Fang W
    Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
    Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
    BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
    Sadaat M; Jang S
    J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy.
    Rajapakse P; Andanamala H
    World J Oncol; 2022 Apr; 13(2):49-52. PubMed ID: 35571340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.
    Kalmuk J; Puchalla J; Feng G; Giri A; Kaczmar J
    Cancers Head Neck; 2020; 5():3. PubMed ID: 32025343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
    Matsuo Y; Iwanami K; Hiraoka E; Oda R
    Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.
    Liu LL; Skribek M; Harmenberg U; Gerling M
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36878533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic Lymphohistiocytosis as the Presenting Manifestation of Relapsed Classic Hodgkin's Lymphoma in the Presence of Concurrent Human Immunodeficiency Virus, Genital Herpes, Epstein-Barr Virus and Mycobacterium Avium Complex Infection.
    Siddiqui RS; Agladze M; Bashir T
    Cureus; 2020 Nov; 12(11):e11563. PubMed ID: 33364090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
    Lee JS; Kang JH; Lee GK; Park HJ
    J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.
    Heynemann S; Vanguru V; Adelstein S; Kao S
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):315-318. PubMed ID: 36562695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
    Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
    Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report.
    Mărginean MO; Molnar E; Chinceşan MI
    Medicine (Baltimore); 2020 Jan; 99(3):e18759. PubMed ID: 32011461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophagocytic lymphohistiocytosis syndrome associated with Epstein-Barr infection in an immunocompetent patient. A case study.
    Ioannou P; Akoumianaki E; Alexakis K; Proklou A; Psyllaki M; Stamatopoulos E; Koulentaki M; Kondili E; Kofteridis DP
    Germs; 2020 Sep; 10(3):266-271. PubMed ID: 33134207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Report of Hemophagocytic Lymphohistiocytosis and Meningitis Due to Atezolizumab Treatment for Lung Adenocarcinoma.
    Ota H; Munechika M; Tobino K; Uchida K; Muarakami Y
    Cureus; 2024 Apr; 16(4):e58253. PubMed ID: 38745801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophagocytic Lymphohistiocytosis Following the anti-PD-1 Nivolumab in a Patient with Gastric Cancer and Ankylosing Spondylitis.
    Long C; Al-Abdulmalek A; Lai J; Haegert DG; Isnard S; Cournoyer D; Routy JP
    Eur J Case Rep Intern Med; 2024; 11(5):004370. PubMed ID: 38715877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
    Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
    Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.